Literature DB >> 23707039

Modeling the heterogeneity of multiple sclerosis in animals.

Sarah B Simmons1, Emily R Pierson, Sarah Y Lee, Joan M Goverman.   

Abstract

Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system (CNS) manifested with varying clinical course, pathology, and inflammatory patterns. There are multiple animal models that reflect different aspects of this heterogeneity. Collectively, these models reveal a balance between pathogenic and regulatory CD4(+) T cells, CD8(+) T cells, and B cells that influences the incidence, timing, and severity of CNS autoimmunity. In this review we discuss experimental autoimmune encephalomyelitis (EAE) models that have been used to study the pathogenic and regulatory roles of these immune cells; models that recapitulate different aspects of the disease seen in patients with MS, and questions remaining for future studies.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  animal models; autoimmunity; experimental autoimmune encephalomyelitis; multiple sclerosis; neuroimmunology

Mesh:

Year:  2013        PMID: 23707039      PMCID: PMC3752929          DOI: 10.1016/j.it.2013.04.006

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  174 in total

1.  Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

Authors:  Ingunn M Stromnes; Lauren M Cerretti; Denny Liggitt; Robert A Harris; Joan M Goverman
Journal:  Nat Med       Date:  2008-02-17       Impact factor: 53.440

Review 2.  Primary progressive multiple sclerosis.

Authors:  A J Thompson; C H Polman; D H Miller; W I McDonald; B Brochet; X Filippi M Montalban; J De Sá
Journal:  Brain       Date:  1997-06       Impact factor: 13.501

3.  Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.

Authors:  C L Vanderlugt; K L Neville; K M Nikcevich; T N Eagar; J A Bluestone; S D Miller
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

4.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

5.  Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.

Authors:  Gurumoorthy Krishnamoorthy; Hans Lassmann; Hartmut Wekerle; Andreas Holz
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

Review 6.  Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis.

Authors:  Moses Rodriguez
Journal:  Brain Pathol       Date:  2007-04       Impact factor: 6.508

7.  Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions.

Authors:  S L Hauser; A K Bhan; F Gilles; M Kemp; C Kerr; H L Weiner
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

Review 8.  The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.

Authors:  Alla L Zozulya; Heinz Wiendl
Journal:  Hum Immunol       Date:  2008-08-22       Impact factor: 2.850

9.  MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8⁺ T cells.

Authors:  Qingyong Ji; Luca Castelli; Joan M Goverman
Journal:  Nat Immunol       Date:  2013-01-06       Impact factor: 25.606

Review 10.  Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein.

Authors:  J Goverman
Journal:  Immunol Rev       Date:  1999-06       Impact factor: 12.988

View more
  87 in total

1.  Thiamine deficiency promotes T cell infiltration in experimental autoimmune encephalomyelitis: the involvement of CCL2.

Authors:  Zhe Ji; Zhiqin Fan; Ying Zhang; Ronghuan Yu; Haihua Yang; Chenghua Zhou; Jia Luo; Zun-Ji Ke
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

2.  Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation.

Authors:  Mako Nakaya; Yichuan Xiao; Xiaofei Zhou; Jae-Hoon Chang; Mikyoung Chang; Xuhong Cheng; Marzenna Blonska; Xin Lin; Shao-Cong Sun
Journal:  Immunity       Date:  2014-05-01       Impact factor: 31.745

3.  Astrocyte-derived lactosylceramide implicated in multiple sclerosis.

Authors:  Abdolmohamad Rostami; Bogoljub Ciric
Journal:  Nat Med       Date:  2014-10       Impact factor: 53.440

4.  Lymphocryptovirus Infection of Nonhuman Primate B Cells Converts Destructive into Productive Processing of the Pathogenic CD8 T Cell Epitope in Myelin Oligodendrocyte Glycoprotein.

Authors:  S Anwar Jagessar; Inge R Holtman; Sam Hofman; Elena Morandi; Nicole Heijmans; Jon D Laman; Bruno Gran; Bart W Faber; Sander I van Kasteren; Bart J L Eggen; Bert A 't Hart
Journal:  J Immunol       Date:  2016-07-13       Impact factor: 5.422

5.  An interferon-β-resistant and NLRP3 inflammasome-independent subtype of EAE with neuronal damage.

Authors:  Makoto Inoue; Po-Han Chen; Stephen Siecinski; Qi-Jing Li; Chunlei Liu; Lawrence Steinman; Simon G Gregory; Eric Benner; Mari L Shinohara
Journal:  Nat Neurosci       Date:  2016-11-07       Impact factor: 24.884

6.  NLRC3 expression in dendritic cells attenuates CD4+ T cell response and autoimmunity.

Authors:  Yuling Fu; Xiaoxia Zhan; Yichong Wang; Xiaobing Jiang; Min Liu; Yalong Yang; Yulan Huang; Xialin Du; Xiao-Ping Zhong; Laisheng Li; Li Ma; Shengfeng Hu
Journal:  EMBO J       Date:  2019-07-10       Impact factor: 11.598

Review 7.  The scales and tales of myelination: using zebrafish and mouse to study myelinating glia.

Authors:  Sarah D Ackerman; Kelly R Monk
Journal:  Brain Res       Date:  2015-10-20       Impact factor: 3.252

Review 8.  Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).

Authors:  Rachel E Klaren; Robert W Motl; Jeffrey A Woods; Stephen D Miller
Journal:  J Neuroimmunol       Date:  2014-06-24       Impact factor: 3.478

Review 9.  Dendritic cells as therapeutic targets in neuroinflammation.

Authors:  Felix Luessi; Frauke Zipp; Esther Witsch
Journal:  Cell Mol Life Sci       Date:  2016-03-12       Impact factor: 9.261

Review 10.  Do not judge a cell by its cover--diversity of CNS resident, adjoining and infiltrating myeloid cells in inflammation.

Authors:  Stefanie M Brendecke; Marco Prinz
Journal:  Semin Immunopathol       Date:  2015-08-07       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.